Colony Capital (CLNY) Stock Rating Upgraded by Zacks Investment Research

Colony Capital (NYSE:CLNY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday. The brokerage currently has a $6.75 price target on the real estate investment trust’s stock. Zacks Investment Research‘s target price would indicate a potential upside of 12.13% from the company’s current price.

According to Zacks, “Colony Capital, Inc. is a real estate and investment management firm. The company focused on investing in real estate and real estate-related assets. It serves health care, industrial and hospitality sectors. The company also offers equity and debt management services. Colony Capital Inc., formerly known as Colony NorthStar Inc., is based in Los Angeles, United States. “

Several other equities research analysts also recently commented on the stock. ValuEngine raised shares of Colony Capital from a “sell” rating to a “hold” rating in a research note on Thursday, November 1st. JMP Securities set a $9.00 target price on shares of Colony Capital and gave the company a “buy” rating in a research note on Tuesday, October 16th.

NYSE:CLNY traded up $0.02 during trading hours on Friday, hitting $6.02. The stock had a trading volume of 2,397,800 shares, compared to its average volume of 5,816,063. Colony Capital has a one year low of $5.28 and a one year high of $12.54. The company has a debt-to-equity ratio of 0.98, a quick ratio of 3.68 and a current ratio of 4.07. The company has a market capitalization of $2.98 billion, a PE ratio of 8.32 and a beta of 1.18.

Colony Capital (NYSE:CLNY) last issued its earnings results on Wednesday, November 7th. The real estate investment trust reported ($0.15) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.13 by ($0.28). Colony Capital had a negative net margin of 17.64% and a negative return on equity of 4.75%. The firm had revenue of $674.77 million during the quarter, compared to the consensus estimate of $673.20 million. The firm’s revenue was down 14.6% compared to the same quarter last year. On average, sell-side analysts forecast that Colony Capital will post 0.58 earnings per share for the current year.

Several institutional investors have recently added to or reduced their stakes in CLNY. State of Alaska Department of Revenue acquired a new position in shares of Colony Capital in the second quarter valued at approximately $1,385,000. Bank of Montreal Can acquired a new position in shares of Colony Capital in the second quarter valued at approximately $526,000. World Asset Management Inc acquired a new position in shares of Colony Capital in the second quarter valued at approximately $126,000. Amalgamated Bank acquired a new position in shares of Colony Capital in the second quarter valued at approximately $584,000. Finally, Nisa Investment Advisors LLC acquired a new position in shares of Colony Capital in the second quarter valued at approximately $705,000. Institutional investors own 80.53% of the company’s stock.

About Colony Capital

Colony Capital, Inc (NYSE: CLNY) is a leading global investment management firm with assets under management of $43 billion. The company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded real estate investment trusts and registered investment companies.

Featured Story: Why do earnings reports matter?

Get a free copy of the Zacks research report on Colony Capital (CLNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Colony Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony Capital and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply